“…Recently, the use of connective tissue progenitor cells derived from SBDCs has come to the fore as an easily accessible, inexpensive, and highly potent biologic augment in the setting of arthroscopic rotator cuff repair. 3 , 9 , 17 , 22 , 24 , 26 , 35 , 36 , 39 More specifically, Morikawa et al found that SBDCs had superior differentiation and proliferation potential compared to concentrated bone marrow aspirate and proposed a feasible method for isolating SBDCs for clinical use. 22 , 24 Interestingly, SBDCs were shown to have a high cellular proliferation potential regardless of patient demographics, rotator cuff tear characteristics, or severity of glenohumeral joint degeneration, alleviating concerns that SBDCs may lose biologic activity in the setting of massive and degenerated rotator cuff tears.…”